
Sign up to save your podcasts
Or


Summary For much of critical care history, immobility was the norm: patients were sedated, kept still, and "protected." But decades of research have revealed the hidden costs — profound muscle wasting, delirium, and long-term disability.
Jonathan explores how our understanding of mobilisation in ICU has evolved — from the recognition of harm caused by bedrest, to the first landmark studies proving that early movement is both feasible and beneficial.
From Bedrest to Better: Why Mobilise in ICU?ICU-acquired weakness: Patients can lose 15–20% of muscle mass within the first week of critical illness.
Long-term outcomes: ARDS survivors tracked for five years showed persistent disability and reduced independence.
Sedation & delirium: Deep sedation increases delirium risk; mobilisation reduces both incidence and duration.
Physiological rationale: Even minimal movement supports cardiovascular tone, respiratory function, circulation, and cognition.
Core message: Bedrest is not neutral — it is actively harmful. Mobilisation offers protection for both brain and body.
Feasibility (Morris et al., 2008): Protocol-led mobilisation cut time to first mobilisation (5 vs 11 days), with no increase in adverse events.
Landmark RCT (Schweickert et al., 2009):
Early PT/OT + daily sedation interruption vs SAT alone.
59% vs 35% regained independence at discharge.
Patients had less delirium and spent fewer days ventilated.
Implementation (Needham et al.): Demonstrated how embedding mobilisation into daily ICU practice improves outcomes and serves as a model for quality improvement.
Core message: Early mobilisation is not only possible — it improves patient-centred outcomes safely.
Bedrest and heavy sedation accelerate weakness, delirium, and disability.
Mobilisation is both biologically plausible and clinically effective.
Early trials proved feasibility, safety, and functional benefits.
Success requires:
Lighter sedation targets and daily SATs.
Interdisciplinary teamwork (nursing, PT/OT, medical).
Structured protocols and safety screens.
Overall message: Mobilisation should no longer be an afterthought in ICU. It is a therapeutic intervention — one that supports recovery, preserves dignity, and helps patients walk out of intensive care with more than just survival.
Sedation practices in the ICU have evolved dramatically over the past decade — but are we truly following the evidence?
In this episode of The Critical Care Practitioner Podcast, Jonathan takes you through the key milestones in sedation guidance, the persistent gap between recommendations and real-world practice, and the emerging shift toward human-centered, wakeful care.
What You'll Learn in This Episode:PAD Guidelines (2013) & beyond: How Barr et al. and later ATS/CHEST summaries shaped modern sedation practice.
Where we fall short: Why deep sedation is still common and the barriers to lighter, protocolised care.
Human-centered sedation: The move from "snowed and stable" to "awake and engaged."
Future directions: Personalised sedation, integrated bundles, non-pharmacologic strategies, and technology-driven monitoring.
Practical takeaways: Simple steps you can apply on your next shift — from setting clear sedation targets to working as a team toward wakefulness and recovery.
Sedation is not passive. It's an active, daily decision that influences survival, recovery, and dignity. The future of ICU care is one where wakefulness is a therapeutic goal — not a risk
Overview In this episode we explore the three main sedatives used in critical care and how to choose the right agent for the right patient.
Highlights
Benzodiazepines: once the workhorse of ICU sedation, but now linked to more delirium and longer ventilation. Still useful in alcohol withdrawal and seizures.
Propofol: rapid on/off, easy to titrate, helpful for daily sedation holds and neuro assessments. Watch for hypotension, lipid issues, and the rare risk of infusion syndrome.
Dexmedetomidine: provides light, cooperative sedation with minimal respiratory depression and less delirium, though bradycardia and hypotension are common drawbacks.
Takeaway No single "best" sedative exists. Match the drug to the patient's needs and clinical goals — and remember, keeping sedation light is often more important than which agent you use.
We've explored the history of sedation in ICU, the impact of daily awakening trials, and the risks of deep sedation. In this episode, we focus on how to embed that evidence into practice — through the use of structured sedation protocols.
Protocols don't just provide guidance; they transform everyday ICU culture, reduce variation in care, and improve outcomes. But implementing them isn't always easy. This episode explores the why, what, and how of sedation protocols — and the cultural shift they demand.
What You'll Learn in This Episode🏥 Why protocols were needed: how variation in sedation practices led to prolonged ICU stays and unpredictable patient journeys.
🧪 What makes up a sedation protocol: RASS targets, daily sedation holds, nurse-led titration, and structured decision-making.
📊 Evidence that protocols work: from Brook's 2000 trial to the PAD guidelines and beyond.
🔄 Barriers to implementation: fear of agitation, staff training gaps, inconsistent documentation, and cultural resistance.
🛠️ Real-world examples: quality improvement projects that boosted compliance and shortened ventilation times.
🎯 Protocols as safety nets: creating safe, evidence-informed defaults while leaving room for clinical judgment.
Brook AD, et al. JAMA. 2000.
Martin J, et al. Intensive Care Med. 2001.
Mehta S, et al. Lancet. 2008.
Barr J, et al. Crit Care Med. 2013 (PAD Guidelines).
Schmidt GA, et al. ATS/Chest Guidelines. 2016.
Mehta S, et al. Crit Care Med. 2012.
Ferraioli S, et al. BMJ Open Qual. 2019.
Sedation protocols are not about rigid rules — they're about shared standards, safety, and empowerment. They help us move from practice variation to consistent, evidence-based care that improves both efficiency and patient outcomes.
If your ICU already uses a protocol, engage with it fully. If not, perhaps it's time to start the conversation
In this third part of our sedation series, we explore one of the biggest game-changers in ICU practice: sedation depth.
For years, the approach was "sedate and stabilise" — often to deep levels. But mounting evidence tells a different story: early deep sedation, especially in the first 48 hours, worsens outcomes.
📉 The risks of deep sedation
Higher hospital and 180-day mortality (SPICE study, Shehabi et al., 2013)
Longer time to extubation and ICU stay
Increased long-term disability
🧠 Sedation and delirium
Strong links between deep sedation and ICU delirium (Ely et al., 2005; Tanaka et al., 2014)
Delirium predicts worse survival and cognitive outcomes
🏥 Impact on ventilation and recovery
More time ventilated
Higher risk of infections
Longer ICU and hospital stays
🛠️ Strategies for safer practice
Set clear sedation targets (RASS –1 to 0)
Protocolised, nurse-driven sedation adjustment
Start light and reassess frequently
Deep sedation only when clearly indicated (e.g., severe ARDS, TBI, refractory agitation)
Takeaway: Early deep sedation is a modifiable risk factor. The mantra is simple: "light unless otherwise indicated." Less really is more — and safer.
In this episode, I explore the origins and evolution of the daily sedation hold — also known as the spontaneous awakening trial (SAT) — one of the most influential shifts in ICU sedation practice.
I unpack the key trials that demonstrated SATs could safely reduce ventilation time and ICU stay, and examines how these findings became standard care. But it's not all straightforward — SATs come with implementation challenges, especially when protocols are already in place.
Key topics:
The evidence behind daily sedation interruption
How SATs reduce ventilation and improve survival
Why some ICUs still hesitate to adopt them
What makes implementation successful in real life
How SATs have reframed sedation from passive to purposeful
Kress et al. (2000). Daily interruption of sedative infusions in critically ill patients.
Girard et al. (2008). Awakening and breathing controlled trial.
Mehta et al. (2012). Daily sedation interruption in protocolized sedation: RCT.
Ferraioli et al. (2019). Quality improvement project on SAT compliance.
Schmidt et al. (2016). ATS/Chest guidelines on sedation minimization
In this episode, I explore how sedation practices in critical care have evolved over time — from the routine use of deep, continuous sedation to the early evidence that challenged it. You'll hear about pivotal studies that revealed the risks of over-sedation, the emergence of structured sedation protocols, and the beginnings of a culture shift toward lighter, more patient-centered care.
Key topics:
The rise of continuous sedation in early ICU care
Landmark studies questioning deep sedation
Early implementation of sedation protocols
How sedation culture began to change
Kress et al. (1998). The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation.
Brook et al. (2000). A prospective evaluation of empiric versus protocol-based sedation and analgesia.
Novaes et al. (1999). Stressors in ICU: perception of the patient, relatives, and health care team.
Martin et al. (2001). Sedative and analgesic practice in the intensive care unit: the results of a European survey
This is a conversation I had with Francesca Trotta, a nurse from Rome who is at the last stages in her PhD. This was at the BACCN conference in Aberdeen in 2024.
This is a chat I had with David Wightwick who is the CEO of UK Med a humanitarian medical aid charity. This happened at the BACCN 2024 conference in Aberdeen.
This is a conversation I had with professor Tim Buchman who is Professor of Surgery and founding director at the Emory Centre for Critical Care in the US.
We discuss the advent of Advanced Practice in the US and how it will inform the same developments in the UK
From the publisher's feed